Agilent, CambTEK Ink Sample Prep Tech Co-marketing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies will co-market CambTEK's extraction and sample prep technologies with its own liquid phase separation, life science, and chemical analysis instruments and software, the companies said today.

Under the agreement, the partners will co-market CambTEK's Rapid Extraction System (RES) for automated sample preparation alongside the Agilent instruments and software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.